Newborn Medicine Annual Pharmacology Conference 2021
New Pharmacological therapies or new use of existing therapies have not yet been published in literature for Neonatal patient population. Prescribing these medications can be low volume, high risk, therefore it benefits the patient and families to have a complete understanding of the pharmacodynamics and kinetics of these drugs. This course will review these therapies.
APPs at UPMC will be better educated and can therefore communicate more effective with subspecialty care teams when caring for these patient populations
Target Audience
Nurse Practitioner
Physician Assistant
Learning Objectives
At the end of this presentation the learner will be able to:
Discuss clinical diagnosis with high seizure risk.
Compare and contrast different seizure treatments and mechanism of action.
Describe the process to Prescribe antiseizure medication.
Discuss clinical diagnosis with high risk of blood clots in newborn/infant.
Compare and contrast different anticoagulation options and mechanisms of action.
Describe the process toPrescribe anticoagulation medication.
Discuss depression/anxiety in the setting of pregnancy.
Compare and contrast antidepressant pharmacotherapy options in pregnancy.
Describe neonatal outcomes in the setting of maternal antidepressant treatments.
Explain how to recognize hypotension in the neonate.
Explain common causes of hypotension in neonates.
Compare and contrast vasoactive medication used to treat hypotension in neonates.
Describe the process to Prescribe vasoactive medications.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for _4_ AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
- This activity has been designated for 3.5 pharmacotherapeutic contact hours. It is the responsibility of the learner to maintain the educational presentation or conference agenda as it may be needed as evidence to validate the contact hour calculation.
Available Credit
- 4.00 AAPA Category I CME
- 4.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 4.00 Attendance